GlassScriptPhysician profile
Charleston Chua
NPI 1881937449
$15,420.53
in general payments reported to CMS, 2019-2025
21 companies · $4,943 in 2025
The $4,943 reported for 2025 was more than what 92% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $151 · 2021: $73.09 · 2022: $95.65 · 2023: $46.04 · 2024: $9,990 · 2025: $4,943.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,783 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,500 · Education: $2,250 · Travel and Lodging: $1,646 · Honoraria: $900 · Consulting Fee: $450 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,782.85 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,500.00 |
| Education | $2,250.00 |
| Travel and Lodging | $1,645.70 |
| Honoraria | $900.00 |
| Consulting Fee | $450.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $450.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $11,518.06 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Tela Bio, INC. | $741.46 | 2024-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Acumed LLC | $732.48 | 2025 | Acumed, Innate Implant |
| Kls-Martin L.P. | $553.59 | 2024-2025 | |
| Motiva USA, LLC | $416.04 | 2024-2025 | |
| Integra Lifesciences Corporation | $287.52 | 2021-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Abbvie INC. | $158.54 | 2024 | |
| Allergan, INC. | $151.40 | 2020 | |
| Biotissue Holdings INC. | $137.21 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $122.95 | 2025 | Cobenfy |
| Endo Pharmaceuticals INC. | $121.84 | 2019 | |
| Mentor Worldwide LLC | $100.35 | 2025 | Artoura Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer, Mentor Siltex Round Spectrum |
| Avita Medical Americas, LLC | $81.04 | 2025 | Recell, Permeaderm, Cohealyx |
| Galderma Laboratories, L.P. | $64.32 | 2023-2025 | Dysport |
| Aroa Biosurgery Incorporated | $52.34 | 2024-2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $42.98 | 2024 | Phasix Mesh |
| Smith+Nephew, INC. | $40.92 | 2025 | Evos Mini |
| Sanara Medtech INC. | $30.00 | 2025 | Celleraterx |
| Bone Support INC. | $27.77 | 2025 | Cerament G, Ceramentbone Void Filler |
| Merz North America, INC. | $22.58 | 2024 | |
| Revance Therapeutics, INC. | $17.14 | 2025 | Daxxify |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charleston Chua listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.